Jiehua Zhou

Jiehua Zhou

Department of Molecular and Cellular Biology, Beckman Research Institute of City of Hope

Affiliated withBeckman Research Institute of City of Hope

Research Area

Biography

Jiehua Zhou has not added Biography.
If you are Jiehua Zhou and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 2
Year
Development of Cell-type specific anti-HIV gp120 aptamers for siRNA delivery
Publication title

Cited by 36

2011
2019

Other Publications

Article
Year
Bombesin/gastrin-releasing peptide receptor: a potential target for antibody-mediated therapy of small cell lung cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research| PubMed ID: 14581370

2003
2004
2005
2006
Targeting gastrin-releasing peptide receptors on small cell lung cancer cells with a bispecific molecule that activates polyclonal T lymphocytes.

Clinical cancer research : an official journal of the American Association for Cancer Research| PubMed ID: 16609038

2006
2006
2007
Novel dual inhibitory function aptamer-siRNA delivery system for HIV-1 therapy.

Molecular therapy : the journal of the American Society of Gene Therapy| PubMed ID: 18461053

2008
Bivalent aptamers deliver the punch.

Chemistry & biology| PubMed ID: 18635000

2008
2009
The therapeutic potential of cell-internalizing aptamers.

Current topics in medicinal chemistry| PubMed ID: 19860714

2009
2010
CTLA-4 blockade following relapse of malignancy after allogeneic stem cell transplantation is associated with T cell activation but not with increased levels of T regulatory cells.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation| PubMed ID: 20713164

2011
Cell-specific aptamer-mediated targeted drug delivery.

Oligonucleotides| PubMed ID: 21182455

2011
2011
2011
Progress in RNAi-based antiviral therapeutics.

Methods in molecular biology (Clifton, N.J.)| PubMed ID: 21431679

2011
Aptamer-targeted RNAi for HIV-1 therapy.

Methods in molecular biology (Clifton, N.J.)| PubMed ID: 21431697

2011
Systemic administration of combinatorial dsiRNAs via nanoparticles efficiently suppresses HIV-1 infection in humanized mice.

Molecular therapy : the journal of the American Society of Gene Therapy| PubMed ID: 21952167

2011
2011
2018
2018